SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Inzucchi SE, Robbins RJ 1994 Clinical review 61: Effects of growth hormone on human bone biology. J Clin Endocrinol Metab 79:691694.
  • 2
    Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC 1998 Growth hormone and bone. Endocr Rev 19:5579.
  • 3
    Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sonksen PH, Tanaka T, Thorne M 1998 Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 83:382395.
  • 4
    Vandeweghe M, Taelman P, Kaufman JM 1993 Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin Endocrinol (Oxf) 39:409415.
  • 5
    Johannsson G, Rosen T, Bosaeus I, Sjostrom L, Bengtsson BA 1996 Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. J Clin Endocrinol Metab 81:28652873.
  • 6
    Janssen YJ, Hamdy NA, Frolich M, Roelfsema F 1998 Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency. J Clin Endocrinol Metab 83:21432148.
  • 7
    Rahim A, Holmes SJ, Adams JE, Shalet SM 1998 Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy. Clin Endocrinol (Oxf) 48:463469.
  • 8
    Kann P, Piepkorn B, Schehler B, Andreas J, Lotz J, Prellwitz W, Beyer J 1998 Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults. Clin Endocrinol (Oxf) 48:561568.
  • 9
    Johannsson G, Rosen T, Bengtsson BA 1998 Four years of growth hormone replacement in adults with growth hormone deficiency: Further increase in bone mineral density. Growth Horm IGF Res 8(Suppl B):194.
  • 10
    Johansson AG, Engstrom BE, Ljunghall S, Karlsson FA, Burman P 1999 Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency. J Clin Endocrinol Metab 84:20022007.
  • 11
    Valimaki MJ, Salmela PI, Salmi J, Viikari J, Kataja M, Turunen H, Soppi E 1999 Effects of 42 months of GH treatment on bone mineral density and bone turnover in GH-deficient adults. Eur J Endocrinol 140:545554.
  • 12
    ter Maaten JC, de Boer H, Kamp O, Stuurman L, van der Veen EA 1999 Long-term effects of growth hormone (GH) replacement in men with childhood-onset GH deficiency. J Clin Endocrinol Metab 84:23732380.
  • 13
    Baum HB, Biller BM, Finkelstein JS, Cannistraro KB, Oppenhein DS, Schoenfeld DA, Michel TH, Wittink H, Klibanski A 1996 Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial. Ann Intern Med 125:883890.
  • 14
    Genant HK, Grampp S, Gluer CC, Faulkner KG, Jergas M, Engelke K, Hagiwara S, Van Kuijk C 1994 Universal standardization for dual X-ray absorptiometry: Patient and phantom cross-calibration results. J Bone Miner Res 9:15031514.
  • 15
    Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N 1994 The diagnosis of osteoporosis. J Bone Miner Res 9:11371141.
  • 16
    Dequeker J 1976 Quantitative radiology: Radiogrammetry of cortical bone. Br J Radiol 49:912920.
  • 17
    Geusens P, Dequeker J, Verstraeten A, Nijs J 1986 Age-, sex-, and menopause-related changes of vertebral and peripheral bone: Population study using dual and single photon absorptiometry and radiogrammetry. J Nucl Med 27:15401549.
  • 18
    Holmes SJ, McKenna SP, Doward LC, Shalet SM 1995 Development of a questionnaire to assess the quality of life of adults with growth hormone deficiency. Endocrinol Metab 2:6369.
  • 19
    Vanderschueren D, Jans I, Van Herck E, Moermans K, Verhaeghe J, Bouillon R 1994 Time-related increase of biochemical markers of bone turnover in androgen-deficient male rats. Bone Miner 26:123131.
  • 20
    Heinegard D, Tiderstrom G 1973 Determination of serum creatinine by a direct colorimetric method. Clin Chim Acta 43:305310.
  • 21
    Bouillon R, Vanderschueren D, Van Herck E, Nielsen HK, Bex M, Heyns W, Van Baelen H 1992 Homologous radioimmunoassay of human osteocalcin. Clin Chem 38:20552060.
  • 22
    Bouillon R, Coopmans W, Degroote DE, Radoux D, Eliard PH 1990 Immunoradiometric assay of parathyrin with polyclonal and monoclonal region-specific antibodies. Clin Chem 36:271276.
  • 23
    Bouillon R, De Moor P, Baggiolini EG, Uskokovic MR 1980 A radioimmunoassay for 1,25-dihydroxycholecalciferol. Clin Chem 26:562567.
  • 24
    Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rosen T, Lindstedt G, Lundberg PA, Bengtsson BA 1994 Serum insulin-like growth factor I in a random population sample of men and women: Relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol (Oxf) 41:351357.
  • 25
    Verbeke G 1997 Linear mixed models for longitudinal data. In: VerbekeG, Molenberghs (eds.), Linear Mixed Models in Practice. An SAS-Oriented Approach. Lecture Notes in Statistics 126. Springer-Verlag, New York, NY, USA, pp. 63154.
  • 26
    Holm S 1979 A simple sequentially rejective Bonferonni test procedure. Scand J Stat 6570.
  • 27
    Rosen T, Hansson T, Granhed H, Szucs J, Bengtsson BA 1993 Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh) 129:201206.
  • 28
    Colao A, Di Somma C, Pivonello R, Loche S, Aimaretti G, Cerbone G, Faggiano A, Corneli G, Ghigo E, Lombardi G 1999 Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism. J Clin Endocrinol Metab 84:19191924.
  • 29
    Thoren M, Soop M, Degerblad M, Saaf M 1993 Preliminary study of the effects of growth hormone substitution therapy on bone mineral density and serum osteocalcin levels in adults with growth hormone deficiency. Acta Endocrinol (Copenh) 128(Suppl 2):4143.
  • 30
    Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalet SM 1994 Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab 78:669674.
  • 31
    Beshyah SA, Freemantle C, Thomas E, Rutherford O, Page B, Murphy M, Johnston DG 1995 Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults. Clin Endocrinol (Oxf) 42:179189.
  • 32
    Brixen K, Hansen TB, Hauge E, Vahl N, Jorgensen JO, Christiansen JS, Mosekilde L, Hagen C, Melsen F 2000 Growth hormone treatment in adults with adult-onset growth hormone deficiency increases iliac crest trabecular bone turnover: A 1-year, double-blind, randomized, placebo-controlled study. J Bone Miner Res 15:293300.
  • 33
    Toogood AA, Adams JE, O'Neill PA, Shalet SM 1997 Elderly patients with adult-onset growth hormone deficiency are not osteopenic. J Clin Endocrinol Metab 82:14621466.
  • 34
    Fernholm R, Bramnert M, Hagg E, Hilding A, Baylink DJ, Mohan S, Thoren M 2000 Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease. J Clin Endocrinol Metab 85:41044112.
  • 35
    Eastell R 1998 Treatment of postmenopausal osteoporosis. N Engl J Med 338:736746.
  • 36
    Wuster C, Slenczka E, Ziegler R 1991 [Increased prevalence of osteoporosis and arteriosclerosis in conventionally substituted anterior pituitary insufficiency: Need for additional growth hormone substitution?]. Klin Wochenschr 69:769773.
  • 37
    Rosen T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Bengtsson BA 1997 Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol 137:240245.
  • 38
    Wuster C, Abs R, Bengtsson BA, Bennmarker H, Feldt-Rasmussen U, Hernberg-Stahl E, Monson JP, Westberg B, Wilton P 2001 The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res 16:398405.
  • 39
    Hoffman DM, O'Sullivan AJ, Baxter RC, Ho KK 1994 Diagnosis of growth-hormone deficiency in adults. Lancet 343:10641068.
  • 40
    Attanasio AF, Lamberts SW, Matranga AM, Birkett MA, Bates PC, Valk NK, Hilsted J, Bengtsson BA, Strasburger CJ 1997 Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group. J Clin Endocrinol Metab 82:8288.
  • 41
    Janssen YJ, Frolich M, Roelfsema F 1997 A low starting dose of genotropin in growth hormone-deficient adults. J Clin Endocrinol Metab 82:129135.
  • 42
    Toogood AA, Jones J, O'Neill PA, Thorner MO, Shalet SM 1998 The diagnosis of severe growth hormone deficiency in elderly patients with hypothalamic-pituitary disease. Clin Endocrinol (Oxf) 48:569576.
  • 43
    Ghigo E, Aimaretti G, Gianotti L, Bellone J, Arvat E, Camanni F 1996 New approach to the diagnosis of growth hormone deficiency in adults. Eur J Endocrinol 134:352356.
  • 44
    Burman P, Johansson AG, Siegbahn A, Vessby B, Karlsson FA 1997 Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. J Clin Endocrinol Metab 82:550555.
  • 45
    Span JP, Pieters GF, Sweep CG, Hermus AR, Smals AG 2000 Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: Role of sex hormone replacement. J Clin Endocrinol Metab 85:11211125.
  • 46
    Drake WM, Coyte D, Camacho-Hubner C, Jivanji NM, Kaltsas G, Wood DF, Trainer PJ, Grossman AB, Besser GM, Monson JP 1998 Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. J Clin Endocrinol Metab 83:39133919.
  • 47
    Cook DM, Ludlam WH, Cook MB 1999 Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults. J Clin Endocrinol Metab 84:39563960.
  • 48
    Quabbe HJ, Plockinger U 1996 Metabolic aspects of acromegaly and its treatment. Metabolism 45:6162.
  • 49
    Bravenboer N, Holzmann P, de Boer H, Roos JC, van der Veen EA, Lips P 1997 The effect of growth hormone (GH) on histomorphometric indices of bone structure and bone turnover in GH-deficient men. J Clin Endocrinol Metab 82:18181822.
  • 50
    Snyder PJ, Peachey H, Berlin JA, Hannoush P, Haddad G, Dlewati A, Santanna J, Loh L, Lenrow DA, Holmes JH, Kapoor SC, Atkinson LE, Strom BL 2000 Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 85:26702677.
  • 51
    Biller BM, Sesmilo G, Baum HB, Hayden D, Schoenfeld D, Klibanski A 2000 Withdrawal of long-term physiological growth hormone (GH) administration: Differential effects on bone density and body composition in men with adult-onset GH deficiency. J Clin Endocrinol Metab 85:970976.
  • 52
    Finkenstedt G, Gasser RW, Hofle G, Watfah C, Fridrich L 1997 Effects of growth hormone (GH) replacement on bone metabolism and mineral density in adult onset of GH deficiency: Results of a double-blind placebo-controlled study with open follow-up. Eur J Endocrinol 136:282289.